Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.92 +0.68 (+0.94%)
As of: Oct 22, 2026 · 11:10 AM EDT

Ani Pharmaceuticals (ANIP) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Ani Pharmaceuticals (ANIP) recorded Net Equity Issued and Repurchased of $308,000 in Q2 2026, down 75.2% from $1.24 million a year earlier and down 86.0% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

On a TTM basis, Ani Pharmaceuticals' Net Equity Issued and Repurchased came in at $12.34 million as of Jun 30, 2026, up 85.0% year-over-year; for FY2025, it was $13.6 million, up 109.7% from FY2024.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 85.6% (FY2020 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $6.49 million in FY2024 (-91.9%), $80.56 million in FY2023, $1.46 million in FY2022 (-97.9%) and $69.58 million in FY2021.
  • Quarterly Net Equity Issued and Repurchased has ranged from $3,000 in Q1 2022 to $80.4 million in Q2 2023 over the past five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased has declined for three consecutive quarters, with growth averaging 92.8% over the last six quarters.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 721.3% in Q3 2025, against a decline of 98.9% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.2 million (Q1 2026), $38,000 (Q4 2025) and $9.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn 138.00 Mn
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn -9.00 Mn
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn 6.00 Mn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn -
10 Ani Pharmaceuticals 1.54 Bn 316.70 Mn 165.89 Mn -505,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -505,000.00
Mar 31, 2026 -17.55 Mn
Dec 31, 2025 -573,000.00
Sep 30, 2025 8.75 Mn
Jun 30, 2025 691,000.00
Mar 31, 2025 -7.47 Mn
Dec 31, 2024 1.38 Mn
Sep 30, 2024 512,000.00
Jun 30, 2024 -295,000.00
Mar 31, 2024 -6.07 Mn
Dec 31, 2023 1.74 Mn
Sep 30, 2023 4.91 Mn
Jun 30, 2023 81.31 Mn
Mar 31, 2023 -3.39 Mn
Dec 31, 2022 649,000.00
Sep 30, 2022 245,000.00
Jun 30, 2022 -280,000.00
Mar 31, 2022 -1.12 Mn
Dec 31, 2021 71.32 Mn
Sep 30, 2021 -73,000.00
API Access

Ani Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANIP&period=max&api_key=YOUR_API_KEY